Chimeric antigen receptor T-cell (CAR-T) therapy has ushered in a new era for the treatment of multiple myeloma (MM). Numerous clinical studies. especially those involving B-cell maturation antigen (BCMA)-directed CAR-T. have shown remarkable efficacy in patients with relapsed or refractory multiple myeloma (R/R MM). https://unionlosangelers.shop/product-category/outerwear/